Chronic Diabetic Complications: Current Challenges and Opportunities
by
and
Ilias N. Migdalis
1,*, 
Leszek Czupryniak
2, 
Nebojsa Lalic
3,
Nikolaos Papanas
4
and
Paul Valensi
5 1
Diabetes Centre, Second Department of Internal Medicine, NIMTS Hospital, 11521 Athens, Greece
2
Department of Internal Medicine and Diabetology, Medical University of Warsaw, 02-097 Warsaw, Poland
3
Faculty of Medicine, University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic Diseases UCC of Serbia, 11000 Belgrade, Serbia
4
Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132 Alexandroupolis, Greece
5
Unit of Endocrinology-Diabetology-Nutrition, AP-HP, Jean Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93140 Bondy, France
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(3), 673; https://doi.org/10.3390/jcm11030673
Submission received: 11 January 2022
/
Accepted: 25 January 2022
/
Published: 28 January 2022
(This article belongs to the Special Issue Chronic Diabetic Complications: Current Challenges and Opportunities)
The Special Issue, “Chronic Diabetic Complications: Current Challenges and Opportunities”, is rich in scientific content, covering a wide field of diabetic complications via both original studies and reviews. Psillas et al. [1] discuss the effects of diabetes mellitus, hypercholesterolaemia and hypertension on Bell’s palsy. Migdalis et al. [2] provide data on agents used to treat hyperglycemia, hypertension and dyslipidemia in subjects with type 2 diabetes mellitus (T2DM) and chronic kidney disease. Margaritidis et al. [3] have shown that Biphasic Insulin Aspart 30 is equally effective to premixed human insulin in controlled subjects with T2DM. Kovářová et al. [4] report that different molecular species of fetuin A influence its variable actions. Further insights into retinopathy and autonomic neuropathy are provided by Hsing et al. [5] and Kempler et al. [6], respectively. In Taiwan, Tai et al. [7] have shown discrepancies between urban and rural areas in terms of diabetic complications. In Italy, Russo et al. [8] have obtained favorable results with edoxaban in patients with atrial fibrillation and diabetes.
Gouveri and Papanas [9] and Penlioglou et al. [10] have revisited olfactory dysfunction and stroke, respectively, in diabetes. Dascalu et al. [11] have conducted a systematic review on diabetic retinopathy following bariatric surgery in T2DM. Baranowska-Jurkun et al. [12] provide an update on microvascular complications in prediabetes. Finally, Koliaki et al. [13] highlight the practical issues and challenges of diabetes management in the COVID-19 era.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Psillas, G.; Dimas, G.G.; Sarafidou, A.; Didangelos, T.; Perifanis, V.; Kaiafa, G.; Mirkopoulou, D.; Tegos, T.; Savopoulos, C.; Constantinidis, J. Evaluation of effects of diabetes mellitus, hypercholesterolemia and hypertension on Bell’s palsy. J. Clin. Med. 2021, 10, 2357. [Google Scholar] [CrossRef]
- Migdalis, I.N.; Papanas, N.; Ioannidis, I.M.; Sotiropoulos, A.E.; Raptis, A.E.; Dimitriadis, G.D.; on behalf of the Hellenic Diabetic Nephropathy Study HDNS. Antidiabetic and other therapies used in subjects with diabetes and chronic kidney disease in a hospital-based clinic population in Greece. J. Clin. Med. 2021, 10, 2104. [Google Scholar] [CrossRef] [PubMed]
- Margaritidis, C.; Karlafti, E.; Kotzakioulafi, E.; Kantartzis, K.; Tziomalos, K.; Kaiafa, G.; Savopoulos, C.; Didangelos, T. Comparison of premixed human insulin 30/70 to biphasic aspart 30 in well-controlled patients with type 2 diabetes using continuous glucose monitoring. J. Clin. Med. 2021, 10, 1982. [Google Scholar] [CrossRef] [PubMed]
- Kovářová, M.; Kalbacher, H.; Peter, A.; Häring, H.U.; Didangelos, T.; Stefan, N.; Birkenfeld, A.; Schleicher, E.; Kantartzis, K. Detection and characterization of phosphorylation, glycosylation, and fatty acid bound to fetuin A in human blood. J. Clin. Med. 2021, 10, 411. [Google Scholar] [CrossRef] [PubMed]
- Hsing, S.C.; Lee, C.C.; Lin, C.; Chen, J.T.; Chen, Y.H.; Fang, W.H. The severity of diabetic retinopathy is an independent factor for the progression of diabetic nephropathy. J. Clin. Med. 2020, 9, 3. [Google Scholar] [CrossRef] [PubMed]
- Kempler, M.; Hajdú, N.; Putz, Z.; Istenes, I.; Vági, O.; Békeffy, M.; Schnabel, K.; Kempler, P.; Körei, A.E. Diabetic cardiovascular autonomic neuropathy, the handgrip test and ambulatory blood pressure monitoring parameters: Are there any diagnostic implications? J. Clin. Med. 2020, 9, 3322. [Google Scholar] [CrossRef] [PubMed]
- Tai, S.Y.; He, J.S.; Kuo, C.T.; Kawachi, I. Urban-rural disparities in the incidence of diabetes-related complications in Taiwan: A propensity score matching analysis. J. Clin. Med. 2020, 9, 3012. [Google Scholar] [CrossRef] [PubMed]
- Russo, V.; Attena, E.; Rago, A.; Melillo, E.; Di Micco, P.; Papa, A.A.; Napolitano, G.; D’Onofrio, A.; Golino, P.; Nigro, G. Clinical outcome of edoxaban vs. vitamin k antagonists in patients with atrial fibrillation and diabetes mellitus: Results from a multicenter, propensity-matched, real-world cohort study. J. Clin. Med. 2020, 9, 1621. [Google Scholar] [CrossRef] [PubMed]
- Gouveri, E.; Papanas, N. Olfactory Dysfunction: A complication of diabetes or a factor that complicates glucose metabolism? A narrative review. J. Clin. Med. 2021, 10, 5637. [Google Scholar] [CrossRef] [PubMed]
- Penlioglou, T.; Stoian, A.P.; Papanas, N. Diabetes, vascular aging and stroke: Old dogs, new tricks? J. Clin. Med. 2021, 10, 4620. [Google Scholar] [CrossRef] [PubMed]
- Dascalu, A.M.; Stoian, A.P.; Cherecheanu, A.P.; Serban, D.; Costea, D.O.; Tudosie, M.S.; Stana, D.; Tanasescu, D.; Sabau, A.D.; Gangura, G.A.; et al. Outcomes of diabetic retinopathy post-bariatric surgery in patients with type 2 diabetes mellitus. J. Clin. Med. 2021, 10, 3736. [Google Scholar] [CrossRef] [PubMed]
- Baranowska-Jurkun, A.; Matuszewski, W.; Bandurska-Stankiewicz, E. Chronic microvascular complications in prediabetic states-an overview. J. Clin. Med. 2020, 9, 3289. [Google Scholar] [CrossRef] [PubMed]
- Koliaki, C.; Tentolouris, A.; Eleftheriadou, I.; Melidonis, A.; Dimitriadis, G.; Tentolouris, N. Clinical management of diabetes mellitus in the era of COVID-19: Practical issues, peculiarities and concerns. J. Clin. Med. 2020, 9, 2288. [Google Scholar] [CrossRef] [PubMed]
- Migdalis, I.N.; Papanas, N.; Raptis, A.E.; Ioannidis, I.M.; Sotiropoulos, A.E.; Dimitriadis, G.D.; Hellenic Diabetic Nephropathy Study (HDNS) Group. The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics. Diabetes Res. Clin. Pract. 2020, 166, 108243. [Google Scholar] [CrossRef] [PubMed]
- Bönhof, G.J.; Herder, C.; Ziegler, D. Diagnostic tools, biomarkers, and treatments in diabetic polyneuropathy and cardiovascular autonomic neuropathy. Curr. Diabetes Rev. 2021, 17, e120421192781. [Google Scholar] [CrossRef] [PubMed]
- Petrova, N.L.; Donaldson, N.K.; Bates, M.; Tang, W.; Jemmott, T.; Morris, V.; Dew, T.; Meacock, L.; Elias, D.A.; Moniz, C.F.; et al. Effect of recombinant human parathyroid hormone (1–84) on resolution of active Charcot neuro-osteoarthropathy in diabetes: A randomized, double-blind, placebo-controlled study. Diabetes Care 2021, 44, 1613–1621. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Migdalis, I.N.; Czupryniak, L.; Lalic, N.; Papanas, N.; Valensi, P. Chronic Diabetic Complications: Current Challenges and Opportunities. J. Clin. Med. 2022, 11, 673. https://doi.org/10.3390/jcm11030673
AMA Style
Migdalis IN, Czupryniak L, Lalic N, Papanas N, Valensi P. Chronic Diabetic Complications: Current Challenges and Opportunities. Journal of Clinical Medicine. 2022; 11(3):673. https://doi.org/10.3390/jcm11030673
Chicago/Turabian StyleMigdalis, Ilias N., Leszek Czupryniak, Nebojsa Lalic, Nikolaos Papanas, and Paul Valensi. 2022. "Chronic Diabetic Complications: Current Challenges and Opportunities" Journal of Clinical Medicine 11, no. 3: 673. https://doi.org/10.3390/jcm11030673
APA StyleMigdalis, I. N., Czupryniak, L., Lalic, N., Papanas, N., & Valensi, P. (2022). Chronic Diabetic Complications: Current Challenges and Opportunities. Journal of Clinical Medicine, 11(3), 673. https://doi.org/10.3390/jcm11030673
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
